Nexgel Inc

Research Nexgel Inc (NXGL) on Bullrun: market cap USD 3.25M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 3.25M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 11.42M-USD 3.00M-USD 1.38M39.5%-0.38USD 317.00KUSD 588.00KUSD 4.46M
FY2024USD 8.69M-USD 3.28M-USD 4.31M31.6%-0.5USD 1.81MUSD 685.00KUSD 5.76M
FY2023USD 4.09M-USD 3.16M-USD 3.93M9.1%-0.56USD 2.70MUSD 838.00KUSD 4.70M
FY2022USD 2.05M-USD 4.75M-USD 3.09M12.5%-0.85USD 1.10MUSD 283.00KUSD 7.64M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-25USD 3.25Mn/an/an/a
20252025-12-31USD 13.11Mn/an/an/a
20242024-12-31USD 34.07Mn/an/an/a
20232023-12-29USD 12.18Mn/an/an/a
20222022-12-30USD 6.97Mn/an/an/a
20212021-12-31USD 14.54Mn/an/an/a

About Nexgel Inc

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also develops NEXDrape, an incise surgical drape designed for patients with impaired skin;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Nexgel Inc's market cap?

Nexgel Inc's market capitalization is USD 3.25M.

What does Nexgel Inc do?

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions.